Circulating Plasma Biomarkers of Progressive Interstitial Lung Disease

Am J Respir Crit Care Med. 2020 Jan 15;201(2):250-253. doi: 10.1164/rccm.201907-1343LE.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alveolitis, Extrinsic Allergic / blood*
  • Alveolitis, Extrinsic Allergic / mortality
  • Alveolitis, Extrinsic Allergic / physiopathology
  • Alveolitis, Extrinsic Allergic / surgery
  • Biomarkers / blood
  • CA-125 Antigen / blood
  • Chemokine CXCL13 / blood
  • Chitinase-3-Like Protein 1 / blood
  • Connective Tissue Diseases / blood
  • Disease Progression
  • Female
  • Humans
  • Lung Diseases, Interstitial / blood*
  • Lung Diseases, Interstitial / mortality
  • Lung Diseases, Interstitial / physiopathology
  • Lung Diseases, Interstitial / surgery
  • Lung Transplantation
  • Male
  • Matrix Metalloproteinase 7 / blood
  • Middle Aged
  • Prognosis
  • Progression-Free Survival
  • Proportional Hazards Models
  • Pulmonary Surfactant-Associated Protein D / blood
  • Vascular Cell Adhesion Molecule-1 / blood
  • Vital Capacity

Substances

  • Biomarkers
  • CA-125 Antigen
  • CHI3L1 protein, human
  • Chemokine CXCL13
  • Chitinase-3-Like Protein 1
  • Pulmonary Surfactant-Associated Protein D
  • Vascular Cell Adhesion Molecule-1
  • Matrix Metalloproteinase 7